Cost assessment of the automated VERSANT™ 440 Molecular System versus the semi-automated System 340 bDNA Analyzer platforms

Expert Review of Molecular Diagnostics

Volumn 7, Issue 6, 2007, Pages 713-722

  Elbeik, Tarek ^a,b   Loftus, Richard A ^b,c   Beringer, Scott ^a,b  

^a Health Management Institute Inc   (United States)

^b California Pacific Medical Center ^*  (United States)

^c CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

bDNA assay; Comparative study; Costs and cost analysis; System 340 bDNA analyzer; VERSANT 440 molecular system; Viral load

Indexed keywords

ARTICLE; BIOSAFETY; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DNA DETERMINATION; DNA HYBRIDIZATION; HEPATITIS C VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; INTERMETHOD COMPARISON; MOLECULAR COMPUTER; NONHUMAN; SOLID WASTE;

BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; COSTS AND COST ANALYSIS; DNA, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD;

EID: 36448956894     PISSN: 14737159     EISSN: 17448352     Source Type: Journal    
DOI: 10.1586/14737159.7.6.713     Document Type: Article

References (13)

1. Gleaves CA, Welle J, Campbell M et al. Multicenter evaluation of the Bayer Versant HIV-1 RNA 3.0 assay: analytical and clinical performance. J. Clin. Virol. 25(2), 205-216 (2002).
2. Elbeik T, Loftus RA, Beringer S. Health care industries' perspective of viral load assays: the VERSANT HIV-1 RNA 3.0 assay. Expert Rev. Mol. Diagn. 2(3), 275-285 (2002).
3. Bushnell S, Budde J, Catino T et al. ProbeDesigner: for the design of probe sets for branched DNA (bDNA) signal amplification assays. Bioinformatics 15(5), 348-355 (1999).
4. Collins ML, Irvine B, Tyner D et al. A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml. Nucleic Acids Res. 25(15), 2979-2984 (1997).
5. Kern D, Collins M, Fultzet T et al. An enhanced-sensitivity branched-DNA assay for quantification of human immunodeficiency virus type 1 RNA in plasma. J. Clin. Microbiol. 34(12), 3196-3202 (1996).
6. Todd J, Pachl C, White R et al. Performance characteristics for the quantitation of plasma HIV-1 RNA using branched DNA signal amplification technology. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 10(Suppl. 2), S35-S44 (1995).
7. Highbarger HC, Alvord GW, Jiang MK et al. Comparison of the Quantiplex version 3.0 assay and a sensitized Amplicor monitor assay for measurement of human immunodeficiency virus type 1 RNA levels in plasma samples. J. Clin. Microbiol. 37(11), 3612-3614 (1999).
8. Elbeik T, Delassandro R, Chen YMA, Soutchkov SV, Loftus, RA, Beringer S. Global cost modeling analysis of HIV-1 and HCV viral load assays. Expert Rev. Pharmacoeconomics Outcomes Res. 3(4), 383-407 (2003). • First publication of viral load comparative cost model describing hidden costs and the most cost-effective way of utilizing the tests described.
9. Elbeik T, Charlebois E, Nassos P et al. Quantitative and cost comparison of ultrasensitive HIV-1 RNA viral load assays: Bayer bDNA Quantiplex versions 3.0 and 2.0 and Roche PCR Amplicor Monitor version 1.5. J. Clin. Microbiol. 38(3), 1113-1120 (2000). • First paper describing a comparative costs analysis between two viral load tests.
10. Rouet F, Rouzioux C. The measurement of HIV-1 viral load in resource-limited settings: how and where? Clin. Lab. 53(3-4), 135-148 (2007). • Significant paper reviewing HIV-1 viral load testing in resource-limited countries.
11. Fiscus SA, Cheng B, Crowe SM et al; Forum for Collaborative HIV Research Alternative Viral Load Assay Working Group. HIV-1 viral load assays for resource-limited settings. PLoS Med. 3(10), E417 (2006). • Review of various viral load tests and the challenges faced in setting up viral load testing centers in resource-limited countries.
12. Martin DJ, Sim J. Laboratory Requirements for Scaling Up HIV Treatment. In: 12th Conference on Retroviruses and Opportunistic Infections. Boston, MA, USA (2005) (Abstract 3).
13. Fisher Scientific online catalog (October 2006) www1.fishersci.com/ browse?cid=1328102 Report on the Global AIDS Epidemic: treatment and care. UNAIDS Joint United Nation Program on HIV/AIDS http://data.unaids.org/pub/ globalreport/20 06/2006_GR_ch07_en.pdf